Recall
FDAHealthJune 2, 2025

Tailstorm Health INC — BUPIVAcaine HCL Sterile injection, USP w/EPINEPHRINE 1:200,000, 50 mg/10mL, 0.5%, (5mg/mL), 10 mL Sterile Single-Dose Vial, Rx Only, For Nerve Block, Caudal & Epidural Anesthesi

⚠️ Lack of Assurance of Sterility: A recent FDA inspection revealed concerns with the sterile manufacturing process.

Is this relevant to me?

Geography
Nationwide
Source agency
FDA
Category
Health
Published
June 2, 2025

Nationwide in the US

What's affected?

Product
BUPIVAcaine HCL Sterile injection, USP w/EPINEPHRINE 1:200,000, 50 mg/10mL, 0.5%, (5mg/mL), 10 mL Sterile Single-Dose Vial, Rx Only, For Nerve Block, Caudal & Epidural Anesthesia Only, Warning: Contains Sulfites, For Office Use Only, Compounded Drug by: Medivant Healthcare, 158 S. Kyrene Rd., Chandler, AZ, 85226, NDC 81483-0036-0.
Lot code
2502005

Additional details

Lot #s: 2502005, Exp. 2/20/26; 2502006, Exp 2/23/2026

What should I do?

Recommended action

Class II recall. Voluntary: Firm initiated Quantity affected: 975 vials.

View original FDA notice →

Get Health recall alerts

Delivered to your inbox. Free. No account required.